PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.677
EU - Europa 2.334
AS - Asia 809
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
SA - Sud America 4
OC - Oceania 1
Totale 7.836
Nazione #
US - Stati Uniti d'America 4.590
DE - Germania 558
IT - Italia 434
SE - Svezia 378
CN - Cina 358
IE - Irlanda 320
SG - Singapore 253
UA - Ucraina 182
RU - Federazione Russa 160
GB - Regno Unito 126
CA - Canada 87
FI - Finlandia 55
HK - Hong Kong 50
TR - Turchia 36
VN - Vietnam 36
IN - India 35
DK - Danimarca 33
BE - Belgio 29
FR - Francia 27
JP - Giappone 12
IR - Iran 9
EU - Europa 7
ID - Indonesia 7
NL - Olanda 7
KR - Corea 6
PL - Polonia 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
AT - Austria 3
BR - Brasile 2
MY - Malesia 2
RO - Romania 2
SC - Seychelles 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
MU - Mauritius 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 7.836
Città #
Ann Arbor 1.069
Woodbridge 418
Fairfield 378
Chandler 347
Houston 343
Frankfurt am Main 315
Dublin 310
Wilmington 247
Ashburn 236
Dearborn 225
Milan 206
Jacksonville 177
Singapore 175
Seattle 167
Cambridge 123
New York 114
Princeton 86
Nanjing 64
Göttingen 61
Shanghai 53
Hong Kong 50
Beijing 45
Altamura 37
Santa Clara 37
Lawrence 36
Brussels 29
Lachine 29
Boardman 28
Ottawa 27
Shenyang 25
Nanchang 24
Dong Ket 23
Fürstenwalde 21
San Diego 21
Munich 20
Andover 19
Fremont 19
Guangzhou 19
Kocaeli 19
Falls Church 17
Helsinki 17
Hebei 16
Tianjin 15
Los Angeles 14
Lissone 13
Toronto 13
Jiaxing 12
Kunming 12
Edmonton 11
Jinan 11
Norwalk 11
Pavia 10
Pune 10
Romola 9
Changsha 8
Kiev 8
London 8
Nürnberg 8
Jakarta 7
Redmond 7
Bonndorf 6
Espoo 6
Hefei 6
Lodz 6
Zanjan 6
Dallas 5
Huizen 5
Ningbo 5
Taku 5
Mountain View 4
Mumbai 4
Paullo 4
Washington 4
Auburn Hills 3
Bari 3
Birmingham 3
Boston 3
Daejeon 3
Kilburn 3
Leawood 3
Montréal 3
Moscow 3
Motta Di Livenza 3
Olomouc 3
Phoenix 3
Quartu Sant'elena 3
Rome 3
Zhengzhou 3
Acton 2
Bangalore 2
Berlin 2
Brno 2
Bryn Mawr 2
Buffalo 2
Chicago 2
Clifton 2
Colle Umberto 2
Crema 2
Faloppio 2
Gessate 2
Totale 6.014
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 395
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 356
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 303
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 300
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 282
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 282
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 272
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 270
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 267
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 257
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 221
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 217
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 200
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 197
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 197
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 197
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 195
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 193
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 193
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 181
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 176
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 170
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 169
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 166
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 162
Whole-Exome Sequencing Data - Identifying Somatic Mutations 161
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 159
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 157
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 154
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 153
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 147
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 147
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 142
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 141
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 137
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 131
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 123
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 114
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 111
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 107
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 86
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 84
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 82
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 67
Totale 8.221
Categoria #
all - tutte 24.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.249 0 0 0 130 154 216 254 102 136 127 94 36
2020/20211.392 70 71 149 166 118 116 145 130 106 134 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/2025487 135 166 120 66 0 0 0 0 0 0 0 0
Totale 8.221